Leadership at the intersection of health, ethics, technology, and law.

Between Feb. 19-26, shares for the telehealth company Hims & Hers Health, Inc. plummeted. The reason for the sudden drop in its stock price? An FDA announcement that semaglutide injection products, the GLP-1 medication in the blockbuster drugs Wegovy and Ozempic, are no longer in shortage.

Transparency rules in clinical trials attempt to strike a balance between ensuring essential safety and efficacy data reaches the public, and preserving truly proprietary information that fosters innovation.

How do we know what is healthy? Given the link between healthy eating patterns and diet-related diseases, consumers need accurate information to make informed choices about which foods they should purchase.

Picture a world where a patient suffering from a debilitating neurological disorder receives not only a diagnosis but also a bespoke brain implant designed to restore lost function.